Cresco Labs Inc.
CL
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 715.76M | 726.35M | 734.82M | 747.27M | 756.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 715.76M | 726.35M | 734.82M | 747.27M | 756.06M |
| Cost of Revenue | 359.89M | 360.10M | 370.67M | 392.28M | 408.52M |
| Gross Profit | 355.87M | 366.26M | 364.15M | 354.99M | 347.54M |
| SG&A Expenses | 221.15M | 219.31M | 223.89M | 237.13M | 256.40M |
| Depreciation & Amortization | 21.77M | 26.29M | 26.53M | 25.69M | 24.54M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 602.81M | 605.69M | 621.09M | 655.10M | 689.46M |
| Operating Income | 112.95M | 120.66M | 113.73M | 92.18M | 66.60M |
| Income Before Tax | -10.62M | -853.00K | -131.37M | -119.95M | -146.90M |
| Income Tax Expenses | 49.87M | 55.21M | 30.45M | 34.14M | 32.95M |
| Earnings from Continuing Operations | -60.49 | -56.06 | -161.81 | -154.10 | -179.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.95M | -11.37M | -10.65M | -569.00K | 4.33M |
| Net Income | -74.44M | -67.43M | -172.46M | -154.66M | -175.52M |
| EBIT | 112.95M | 120.66M | 113.73M | 92.18M | 66.60M |
| EBITDA | 172.05M | 186.10M | 179.54M | 157.06M | 129.11M |
| EPS Basic | -0.22 | -0.20 | -0.51 | -0.47 | -0.54 |
| Normalized Basic EPS | -0.06 | -0.04 | -0.04 | 0.05 | 0.01 |
| EPS Diluted | -0.22 | -0.20 | -0.51 | -0.47 | -0.54 |
| Normalized Diluted EPS | -0.06 | -0.04 | -0.04 | 0.05 | 0.01 |
| Average Basic Shares Outstanding | 1.38B | 1.37B | 1.36B | 1.33B | 1.29B |
| Average Diluted Shares Outstanding | 1.38B | 1.37B | 1.36B | 1.33B | 1.29B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.27% | -0.30% | -- | -- | -- |